Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Empro Group's EV-to-EBIT or its related term are showing as below:
EMPG's EV-to-EBIT is not ranked *
in the Medical Distribution industry.
Industry Median: 12.21 * Ranked among companies with meaningful EV-to-EBIT only.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Empro Group's Enterprise Value for the quarter that ended in Dec. 2024 was $0.00 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Empro Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was $1.10 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Empro Group EV-to-EBIT Related Terms
Empro Group EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Empro Group's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Empro Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Empro Group EV-to-EBIT vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Empro Group's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Empro Group's EV-to-EBIT falls into.
Empro Group's current Enterprise Value is $144.46 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Empro Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was $1.10 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Empro Group (EMPG) has a EV-to-EBIT of 130.97 as of Aug. 27, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Empro Group and its competitors.
Is Empro Group's EV-to-EBIT too high?
Empro Group's current EV-to-EBIT is 130.97. The Medical Distribution industry median EV-to-EBIT is 12.21. Empro Group's value of 130.97 is 972.6% above this industry median. Overall, Empro Group has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Empro Group's EV-to-EBIT compare to EDAP and OMI?
Empro Group's EV-to-EBIT of 130.97 can be compared against companies in the Medical Distribution industry. The industry median EV-to-EBIT is 12.21. Empro Group's value of 130.97 is 972.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Distribution company?
The median EV-to-EBIT among Medical Distribution companies is 12.21, based on 97 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Empro Group's current EV-to-EBIT of 130.97 is 972.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Empro Group and its competitors. For the Medical Distribution industry, the median EV-to-EBIT is 12.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Empro Group's current EV-to-EBIT is 130.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Empro Group stock overvalued right now?
Empro Group (EMPG) has a current EV-to-EBIT of 130.97. The current EV-to-EBIT is 130.97 and 972.6% above the Medical Distribution industry median of 12.21. Empro Group's overall GF Score™ is 28/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Empro Group (EMPG), the current EV-to-EBIT is 130.97 as of Aug. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Address21, Jalan 15/23, Tiong Nam Industry Park, Shah Alam, SGR, MYS, 40200
Empro Group Inc operates in the Health and Beauty industry, focusing on enhancing well-being and confidence through a combination of skincare, cosmetics, healthcare products, and embroidery services. The company derives majority of its revenue from health care business segment involves trading and wholesaling of medical masks, COVID-19 test kits and related products.
28GF Score
Get the complete analysis for EMPG
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EMPG has been successfully added to your 
